Purchase Order 12405B23P0401
Award Date 9/1/23
Potential Completion Date 3/1/24
Potential Value $25K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
New Orleans, LA 70124, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $88,327.43, was issued by the U.S. Department of Agriculture (USDA) to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract, which is a firm fixed-price purchase order, is for the provision of DNA fragments with 100% guaranteed sequence to support the USDA's Agricultural Research Service (ARS) Plains Area. This award is set aside for small businesses and was made under a solicitation that had a North American Industry...
- The U.S. government awarded a $5,126.85 firm fixed price purchase order to Genscript USA Inc. for monoexpress basic antibody service. The contract was awarded on May 11, 2017, with an ultimate completion date of November 11, 2017, and does not utilize a set-aside designation. The place of performance is New Orleans, Louisiana, and the funding originates from a civilian federal agency within the Southeast Area. Genscript USA Inc., a biotechnology company headquartered in Piscataway, New Jersey,...
- This federal contract was awarded by the Plains Area division of a civilian federal agency to Genscript USA Inc., a biotechnology company based in New Jersey. The $3,458.11 firm fixed-price purchase order is for protein expression and purification services. The contract does not have a set-aside designation. Genscript has received numerous prime and subcontract awards from federal agencies like the Department of Health and Human Services (including the National Institutes of Health, Centers...
- The U.S. Department of Agriculture's Midwest Area awarded a $3,371.61 firm fixed-price purchase order to Genscript USA Inc. for protein sequencing services on May 18, 2015, with completion targeted for May 31, 2016. The contract, issued without a set-aside designation, leverages Genscript's specialized capabilities in molecular biology and protein production to support federal research initiatives. Performance will be executed at the contractor's facility in Piscataway, New Jersey. Genscript USA...
- The U.S. government awarded a purchase order valued at $5,075.85 to Genscript USA Inc., a biotechnology company headquartered in Piscataway, New Jersey, for monoclonal antibody products. The contract, awarded on September 19, 2016, with an ultimate completion date of March 20, 2017, was issued under a firm fixed-price pricing structure by a civilian federal agency (Southeast Area). No set-aside designation was applied to this award. The place of performance is located in Piscataway, New...
- This is a $164,700 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Genscript USA Inc., a biotechnology company in Piscataway, New Jersey. The contract is for the provision of monoclonal antibodies and plasmids services to support critical research initiatives, with a period of performance through June 15, 2026. While the contract does not have a set-aside...
- The U.S. government awarded a $6,576.20 firm fixed-price purchase order to Genscript USA Inc. for the production of rabbit polyclonal antibodies against the chicken PCD1-1 immunoglobulin V domain. The contract, awarded on June 12, 2023, with an ultimate completion date of December 29, 2023, was funded by a civilian Southeast Area agency. Work is to be performed in East Lansing, Michigan. This contract represents a non-set-aside award to the Piscataway, New Jersey-based biotechnology firm,...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The $164,700.00 firm fixed-price purchase order is for monoclonal antibodies and plasmids services, with a completion date of June 14, 2026. The contract does not have a set-aside designation. Genscript is a key supplier of...
- The U.S. Department of Agriculture (USDA) Agricultural Research Service Western Regional Research Center awarded a firm fixed-price purchase order contract to Personalized Bioinformatics, LLC for the delivery of 10 milligrams each of high-priority antibodies as specified in Quotation #1715 dated September 22, 2015. The contract, valued at $25,600.00, was executed on November 19, 2015, with a completion deadline of December 31, 2015. The vendor will deliver the antibodies to the USDA Agricultural...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract, valued at $3,800.00, is for custom monoclonal antibody production services to support NIAID's biomedical research and public health initiatives. This contract does not have a set-aside designation. Genscript...
The Department of Agriculture Agricultural Research Service Field Research Implementation and Information Delivery awarded a purchase order valued at $24,796.45 to Genscript USA Inc. The contract calls for Genscript to provide custom anti car I 2 monoclonal antibody in support of USDA research efforts. Specifically, the solicitation requested quotes for the antibody meeting associated technical specifications, price breakdowns, and descriptive literature demonstrating compliance. The place of performance is New Orleans, Louisiana and the period of performance spans from September 1, 2023 to March 1, 2024. This contract has a total small business set aside designation.
Generated 12/23/23, 9:30 PM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Custom anticar i2 monoclonal antibody | 12405B23Q0589 | Department of Agriculture Agricultural Research Service Field Research Implementation and Information Delivery | Solicitation 1/1 | 8/11/23, 4:42 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.8k | 9/1/23 |